GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3151 - 3175 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgA Patient 1 10 moderate
G17390SF
387
IgA Patient 1 22 moderate
G17390SF
381
IgA Patient 1 6 moderate
G17390SF
348
IgG Patient 1 10 moderate
G17390SF
25
IgG Patient 1 22 moderate
G17390SF
28
IgG Patient 1 6 moderate
G17390SF
27
IgM Patient 1 10 moderate
G17390SF
34
IgM Patient 1 22 moderate
G17390SF
51
IgM Patient 1 6 moderate
G17390SF
38
IgA Patient 2 15 mild
G17390SF
382
IgA Patient 2 24 mild
G17390SF
456
IgG Patient 2 15 mild
G17390SF
34
IgG Patient 2 24 mild
G17390SF
37
IgM Patient 2 15 mild
G17390SF
137
IgM Patient 2 24 mild
G17390SF
144
IgA Patient 2 3 mild
G17390SF
516
IgG Patient 2 3 mild
G17390SF
52
IgM Patient 2 3 mild
G17390SF
264
IgA Patient 3 -180 mild
G17390SF
280
IgA Patient 3 11 mild
G17390SF
429
IgG Patient 3 -180 mild
G17390SF
50
IgG Patient 3 11 mild
G17390SF
51
IgM Patient 3 -180 mild
G17390SF
94
IgA Patient 3 4 mild
G17390SF
367
IgG Patient 3 4 mild
G17390SF
37

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024